HomeAI · summaries
Storia in 2 fonti
New Anaphylm sublingual epinephrine data address FDA’s concerns
Multiple human factors improved following revision of the packaging design and instructions for use on Anaphylm sublingual epinephrine film, according to topline results.As Healio previously reported, the FDA cited concerns about human factors in the use of Aquestive Therapeutics’ Anaphylm (dibutepinephrine) for anaphylaxis and other type 1 allergic reactions in its complete response letter
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study - Aquestive T
Aquestive Therapeutics reports positive study results for Anaphylm sublingual film, paving the way for a Q3 FDA resubmission.
- ·
healio.com
New Anaphylm sublingual epinephrine data address FDA’s concerns
Multiple human factors improved following revision of the packaging design and instructions for use on Anaphylm sublingual epinephrine film, according to topline results.As Healio…